SMTL ID : 4rzv.2 (1 other biounit)

Crystal structure of the BRAF (R509H) kinase domain monomer bound to Vemurafenib

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.99 Å

Oligo State

monomer

Ligands

1 x 032: N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide(Non-covalent)

032.1: 20 residues within 4Å: Chain A: I.21, V.29, A.39, V.40, K.41, L.72, F.74, I.85, T.87, Q.88, W.89, C.90, S.93, S.94, H.97, F.141, G.151, D.152, F.153, G.154 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:I.21, A:A.39, A:K.41, A:L.72, A:F.74, A:T.87, A:T.87, A:W.89, A:F.141, A:F.141, A:F.153, A:F.153 Hydrogen bonds: A:K.41, A:T.87, A:Q.88, A:C.90, A:D.152, A:D.152, A:F.153, A:G.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Karoulia, Z. et al., An integrated model of RAF inhibitor action predicts inhibitor activity against oncogenic BRAF signaling. Cancer Cell (2016)

Release Date

2016-08-10

Peptides

Serine/threonine-protein kinase B-raf: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase B-raf

Related Entries With Identical Sequence